Deutsche Bank Ag\ Applied Molecular Transport Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.76 - $7.65 $39,578 - $109,701	-14,340 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.63 - $13.88 $9,120 - $22,485	-1,620 Reduced 10.15%	14,340 $108,000
Q4 2021 Feb 11, 2022	SELL	$13.23 - $26.05 $50,657 - $99,745	-3,829 Reduced 19.35%	15,960 $224,000
Q3 2021 Nov 04, 2021	BUY	$25.87 - $46.61 $114,759 - $206,761	4,436 Added 28.89%	19,789 $512,000
Q2 2021 Aug 11, 2021	BUY	$39.76 - $64.31 $24,730 - $40,000	622 Added 4.22%	15,353 $703,000
Q1 2021 May 13, 2021	BUY	$30.5 - $74.14 $171,166 - $416,073	5,612 Added 61.54%	14,731 $648,000
Q4 2020 Feb 16, 2021	BUY	$29.39 - $35.0 $73,092 - $87,045	2,487 Added 37.5%	9,119 $281,000
Q3 2020 Nov 12, 2020	BUY	$20.49 - $33.58 $135,889 - $222,702	6,632 New	6,632 $211,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.